Brady Todd C 4
4 · Aldeyra Therapeutics, Inc. · Filed Mar 6, 2025
Insider Transaction Report
Form 4
Brady Todd C
DirectorPresident and CEO
Transactions
- Award
Stock Option (right to buy)
2025-03-04+809,710→ 809,710 totalExercise: $6.17Exp: 2035-03-03→ Common Stock (809,710 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2025.